Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

Blue eye | Image credit: Vladimir Voronin - stock.adobe.com
Double-Dose Aflibercept Relieved Treatment Burden, Displayed Anatomic Gains Compared With Regular Dose

May 23rd 2024

An aflibercept dose of 4 mg for macular degeneration was found to reduce both central macular thickness and pigmental epithelium detachment for a longer duration compared with the 2 mg dose.

Close of up of an older woman's eye | Image credit: Syda Productions - stock.adobe.com
First Aflibercept Biosimilars Approved in US

May 20th 2024

Woman's Eyes | Image credit: Africa Studio - stock.adobe.com
Visual Acuity, Retinal Sensitivity Improved With Intravitreal Ranibizumab Injection

May 14th 2024

Older woman with Glaucoma | Image credit: Africa Studio - stock.adobe.com
Visual Field Progression, Doubling Risk of Event Progression Associated With Density Loss in Optic Nerve

May 8th 2024

Artificial Intelligence | Image credit: Tierney - stock.adobe.com
Code-Free Models Effective at Classifying Retinal Pathologies

May 1st 2024

Continuing Medical Education
May 29th 2024

Improving Outcomes and Quality of Care in Age-Related Macular Degeneration and Diabetic Macular Edema: Patient-Centered Strategies in Managed Care

3.0 Credits / Ophthalmology/Optometry
May 29th 2024

Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars

1.0 Credit / Ophthalmology/Optometry
May 29th 2024

Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care

2.0 Credits / Ophthalmology

More News

Human eye.
June 5th 2021

Ophthalmology Overview: Bevacizumab for Wet AMD, AI in Retinal Disease Management, and More

AJMC Staff
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
green color
June 4th 2021

Lighting System Quality May Impact Color Discrimination in Patients With Glaucoma

Jaime Rosenberg
Patients with glaucoma who were tested under a quantum dot LED were able to better distinguish differences in color, indicating that the quality of light systems may have an impact on color discrimination.
Human eye.
May 29th 2021

Ophthalmology Overview: Gene Therapy Partially Restores Vision in Blind Patient, Presbyopia Therapy, and More

AJMC Staff
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Genetic code, double-helix
May 27th 2021

Sex Likely Not a Disease-Modifying Factor Among Women, Men With Stargardt Disease

Larry Hanover
A reported association between sex and mild ABCA4 alleles among patients with Stargardt disease did not hold up upon reevaluation.
Email being sent
May 25th 2021

What We’re Reading: Restoring Eyesight; New Moderna Vaccine Indication Possible; COVID-19 Origin Investigation

AJMC Staff
Optogenics was used to partially restore a blind man’s eyesight; the FDA could soon approve Moderna’s COVID-19 vaccine for use among adolescents; HHS calls for a new investigation into COVID-19’s origins.
Infected eye.
May 21st 2021

Ophthalmology Overview: COVID-19 Infection in Eye Cells, Vision Loss and Blindness Prevalence, and More

AJMC Staff
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Novel Method Evaluates Progression of Sickle Cell Retinopathy
May 20th 2021

Novel Method Evaluates Progression of Sickle Cell Retinopathy

Larry Hanover
The technique uses optical coherence tomography angiography to assess the motion of blood flow, instead of static images.
Human eye.
May 14th 2021

Ophthalmology Overview: Progress in Diabetic Retinopathy Management, Nurse Involvement in Retinal Care, and More

Matthew Gavidia
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
RVO Stabilizes, but Does Not Improve, With Dexamethasone Implant, Study Says
May 8th 2021

RVO Stabilizes, but Does Not Improve, With Dexamethasone Implant, Study Says

Larry Hanover
Intravitreal dexamethasone implants stabilized, but did not improve, vision for most patients with macular edema due to retinal vein occlusion (RVO).
Racial, Ethnic Disparities Seen in Ophthalmology Drug Trials, Study Says
April 30th 2021

Racial, Ethnic Disparities Seen in Ophthalmology Drug Trials, Study Says

Larry Hanover
Blacks and Hispanics were underrepresented in relation to their US racial distribution in clinical trials for ophthalmology drug approvals from 2000 to 2020.
eyeball graphic
April 25th 2021

Examining the Relationship Between Anti-VEGF Drugs and Major Cardiovascular Events

Larry Hanover
According to a recent review, intravitreal anti-vascular endothelial growth (anti-VEGF) drugs were not associated with an increase in major cardiovascular events.
Optical coherence tomography (OCT) appears to be less stressful to preterm infants
April 21st 2021

OCT Easier on Infants Than Typical US Method in Determining ROP, Study Says

Larry Hanover
Optical coherence tomography (OCT) appears to be less stressful to preterm infants than ocular indirect ophthalmoscopy (BIO) in assessing retinopathy of prematurity (ROP).
baby held by masked doctor
April 19th 2021

Low Rate of Ocular Abnormalities Seen Among Newborns Exposed to SARS-CoV-2 In Utero

Skylar Jeremias
A study of newborns exposed to SARS-CoV-2, the virus that causes COVID-19, during gestation found few instances of ocular abnormalities, with none detected in exposed infants who testing positive.
Newborn infant
April 13th 2021

Optimal Oxygen Saturation to Ward Off ROP Remains Unknown

Larry Hanover
Higher oxygen saturation targets are linked with greater progression in some cases of retinopathy of prematurity (ROP), but the incidence remains stable.
stacks of dimes
April 9th 2021

Evaluating Cost Savings of Adenoviral Conjunctivitis PCR Testing Among Employees

Larry Hanover
Polymerase chain reaction testing of suspected cases of adenoviral conjunctivitis in a hospital setting resulted in large cost savings by avoiding unnecessary employee furloughs.
Therapy Slows Diabetic Retinopathy but Vision Loss Benefit No Better Than Regular Care
April 7th 2021

Therapy Slows Diabetic Retinopathy but Vision Loss Benefit No Better Than Regular Care

Larry Hanover
More information will come from 4-year results, which will be critical to assess whether there is any long-term benefit to visual acuity using aflibercept.
computer chip
March 31st 2021

Machine Learning Helps Identify Eyes With Pathologic Myopia

Gianna Melillo
Using a support vector machine model, researchers were able to distinguish between eyes with pathologic myopia and healthy myopia.
magnifying glass over a data sheet
March 30th 2021

Formulas May Predict Visual Acuity in Patients With Astigmatism

Gianna Melillo
Researchers developed regression formulas that may be clinically beneficial for estimating visual prognosis after astigmatic correction and determining the surgical indication of astigmatic correction.
Red, irritated eye
March 23rd 2021

Study Finds Higher Rates of Hearing Loss Associated With Teprotumumab

Gianna Melillo
Study findings presented at ENDO 2021, the Endocrine Society's annual meeting, show rates of hearing loss among 28 patients who took teprotumumab were higher than previously reported in phase 2 and 3 trials.
Comparing Treatment Outcomes in Eyes With Proliferative Diabetic Retinopathy and NVE, NVD
March 22nd 2021

Comparing Treatment Outcomes in Eyes With Proliferative Diabetic Retinopathy and NVE, NVD

Gianna Melillo
Disc neovascularization (NVD) was less frequent among patients with proliferative diabetic retinopathy but was associated with more resistance to currently available treatments compared with neovascularization elsewhere (NVE), according to post hoc analysis findings published in JAMA Ophthalmology.
Fear of COVID-19 Limits Patients’ Uptake of Ophthalmic Care
March 16th 2021

Fear of COVID-19 Limits Patients’ Uptake of Ophthalmic Care

Gianna Melillo
Fear of exposure to COVID-19 is associated with patients missing ophthalmic care appointments, suggesting the potential importance of conveying practices’ infection-control measures, according to results of a non-validated survey.
Macular Damage May Lead to Impaired Facial Recognition
March 15th 2021

Macular Damage May Lead to Impaired Facial Recognition

Gianna Melillo
Field loss may not be the only visual deficit resulting from macular damage while resulting functional losses may impair facial recognition, according to new research published in JAMA Ophthalmology.
Program Aims to Increase Genetic Testing for Inherited Retinal Degenerations
March 10th 2021

Program Aims to Increase Genetic Testing for Inherited Retinal Degenerations

Gianna Melillo
Implementation of the free My Retina Tracker Genetic Testing Study program was associated with an increased proportion of patients with inherited retinal degeneration successfully obtaining genetic testing, according to analysis results published in JAMA Ophthalmology.
Early Months of Pandemic Saw Decreased Rates of Vitreoretinal Surgical Procedures
March 8th 2021

Early Months of Pandemic Saw Decreased Rates of Vitreoretinal Surgical Procedures

Gianna Melillo
Early in the COVID-19 pandemic, there was a nationwide decrease in critical vitreoretinal surgical procedures deemed as urgent or emergent, according to findings published in JAMA Ophthalmology.
Scheimpflug Imaging Helps Predict Corneal Edema Resolution After DMEK
March 3rd 2021

Scheimpflug Imaging Helps Predict Corneal Edema Resolution After DMEK

Gianna Melillo
Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial keratoplasty (DMEK).
Study Supports Preschool-Based Vision Screening Programs to Increase Glasses Wear
March 1st 2021

Study Supports Preschool-Based Vision Screening Programs to Increase Glasses Wear

Gianna Melillo
Research published in JAMA Ophthalmology supports the continued implementation of preschool-based vision screening programs, as nearly 3 of 4 preschool students consistently wore their glasses at school during the first year of use.
Survey: Thyroid Eye Disease Reduces Quality of Life Beyond Acute Phase
February 25th 2021

Survey: Thyroid Eye Disease Reduces Quality of Life Beyond Acute Phase

Gianna Melillo
A new survey conducted by Horizon Therapeutics highlighted the negative impacts thyroid eye disease have on patients’ quality of life, finding effects often continue beyond the acute disease phase and into a chronic phase.
Investigation Finds Tuberculosis May Be Risk Factor for Behçet Disease
February 23rd 2021

Investigation Finds Tuberculosis May Be Risk Factor for Behçet Disease

Gianna Melillo
An analysis of human genetic and biomarker data found that tuberculosis was a risk factor for Behçet disease, a noninfectious uveitis condition.
Eye Health
February 19th 2021

Central Retinal Artery Occlusion Rates in Korea Decreased Over Time, Study Finds

Rose McNulty
Rates of central retinal artery occlusion (CRAO), which is associated with and shares common risk factors with cardiovascular diseases, have decreased over time in Korea, a recent cohort study of 50 million residents found.
Umbrella Review Highlights Global Scope of Vision Impairment, Reduced Quality of Life
February 16th 2021

Umbrella Review Highlights Global Scope of Vision Impairment, Reduced Quality of Life

Gianna Melillo
A global analysis of 9 systematic reviews found a consistent association between vision impairment, eye diseases, and reduced quality of life.
<1
...
67891011121314
...
16>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences™ and AJMC®.
All rights reserved.

About Us
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo